NCT07226973 Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior
| NCT ID | NCT07226973 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ochsner Health System |
| Condition | Osteoarthritis (OA) of the Hip |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-10-09 |
| Primary Completion | 2027-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-10-09 with a primary completion date of 2027-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the gait biomechanics following THA on 3 groups of subjects undergoing DAA (manual) and PA (manual and robotic) surgical approaches.
Eligibility Criteria
Inclusion Criteria: * Adults aged \>18 undergoing primary elective THA for osteoarthritis * BMI \<35 * Ability to walk unassisted (cane, walker, wheelchair, ect) for \> 150 feet preoperatively Exclusion Criteria: * Previous hip surgery on the affected side * Neurological disorders affecting gait * Contraindication to either DAA or PA
Contact & Investigator
George Chimento, MD
PRINCIPAL INVESTIGATOR
Ochsner Health System
Frequently Asked Questions
Who can join the NCT07226973 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis (OA) of the Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07226973 currently recruiting?
Yes, NCT07226973 is actively recruiting participants. Contact the research team at gchimento@ochsner.org for enrollment information.
Where is the NCT07226973 trial being conducted?
This trial is being conducted at Metairie, United States, New Orleans, United States.
Who is sponsoring the NCT07226973 clinical trial?
NCT07226973 is sponsored by Ochsner Health System. The principal investigator is George Chimento, MD at Ochsner Health System. The trial plans to enroll 48 participants.